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Edited by Jesus AvilaAbstract Ca2+/calmodulin-dependent protein kinase kinase a
(CaMKKa) plays critical roles in the modulation of neuronal cell
survival as well as many other cellular activities. Here we show
that 14-3-3 proteins directly regulate CaMKKa when the enzyme
is phosphorylated by protein kinase A on either Ser74 or Ser475.
Mutational analysis revealed that these two serines are both
functional: the CaMKKa mutant with a mutation at either of
these residues, but not the double mutant, was inhibited signiﬁ-
cantly by 14-3-3. The mode of regulation described herein diﬀers
the recently described mode of 14-3-3 regulation of CaMKKa.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The 14-3-3 family is comprised of acidic, dimeric proteins
with subunit molecular masses of 30 kDa that are widely dis-
tributed among eukaryotic cells. Numerous biological activi-
ties have been ascribed to this protein family, including
activation of enzymes involved in neurotransmitter synthesis,
regulation of signaling enzymes important for cell proliferation
and survival, and modulation of proteins that are deregulated
in diﬀerent forms of cancer, diabetes, or neurodegenerative dis-
orders [1–4]. There are currently over 150 proteins that have
been identiﬁed as 14-3-3-binding partners. Recent proteomic
studies suggest that eukaryotic cells contain several hundred
additional proteins whose functions might be regulated by
14-3-3 proteins. In most of these cases, 14-3-3 binding depends
on phosphorylation of the target protein, especially at speciﬁcAbbreviations: CaMKKa, Ca2+/calmodulin-dependent protein kinase
kinase a; CaMKI, Ca2+/calmodulin-dependent protein kinase I;
CaMKIV, Ca2+/calmodulin-dependent protein kinase IV; PKA,
cAMP-dependent protein kinase A; MAPK, mitogen-activated protein
kinase; PKB, protein kinase B; CaM, calmodulin; GST, glutathione
S-transferase; WT, wild-type
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doi:10.1016/j.febslet.2008.01.037serine residues [5]. Based on these ﬁndings, it has been pro-
posed that 14-3-3 proteins are key regulators or integrators
for a variety of cell signaling pathways mediated by protein
phosphorylation.
Ca2+/calmodulin-dependent protein kinase kinase a (CaM-
KKa) is a member of the multifunctional Ca2+/calmodulin-
dependent protein kinase (CaMK) cascade and functions as
the ﬁrst step enzyme of this cascade that also includes Ca2+/
calmodulin-dependent protein kinase I (CaMKI) and Ca2+/
calmodulin-dependent protein kinase IV (CaMKIV) that are
phosphorylated and activated by CaMKKa (and possibly
CaMKKb). There is extensive cross-talk between this kinase
cascade and other signal transduction pathways, such as those
that involve mitogen-activated protein kinase (MAPK), pro-
tein kinase B (PKB), and cAMP-dependent protein kinase A
(PKA) [6]. Recently, Davare et al. [7] reported that 14-3-3 also
participates in this crosstalk in concert with PKA-catalyzed
phosphorylation of CaMKKa. Using a GST-fused CaMKKa
protein, they demonstrated that 14-3-3 speciﬁcally binds the
fused enzyme through PKA-phosphorylated Ser74 and
suppresses its catalytic activity. However, the 14-3-3 inhibitory
eﬀect was only detectable in a Thr108/Ser458 CaMKKa
double point mutant and was not detectable in the wild-type
enzyme [7]. The 14-3-3 protein regulates many enzymatic activ-
ities in a direct manner; thus, the reported regulation of CaM-
KKa by 14-3-3 is relatively uncommon.
Using a quantitative proteomics approach, we recently iden-
tiﬁed CaMKKa as a forskolin (activator of PKA)-induced, 14-
3-3-binding partner in rat pheochromocytoma PC12Mh cells
(a monoclonal PC12 cell line stably expressing a MEF (myc-
TEV-FLAG)-fused version of the 14-3-3g isoform [8]). Here,
we report that the binding of 14-3-3 to CaMKKa can directly
inhibit CaMKKa activity by decreasing the Vmax value of the
enzyme. We also demonstrate that this inhibition is associated
with PKA-dependent phosphorylation of either Ser74 or
Ser475, both of which are highly conserved among various
CaMKKs, including CaMKKb.2. Materials and methods
2.1. Materials
The bacterial expression plasmids carrying wild-type (WT) CaM-
KKa (WT-CaMKKa) and its phosphorylation mutants (S74A and
S475A) were kindly provided by Dr. Takako Kitani at Asahikawa
Medical College. The double or quadruple mutants of CaMKKablished by Elsevier B.V. All rights reserved.
Fig. 1. Binding of 14-3-3 to CaMKKa in forskolin-stimulated PC12
cells. (A) Endogenous CaMKKa was immunoprecipitated from PC12
cells treated with 50 mM forskolin (20 min) using control or CaMKKa
antibodies. The immunoprecipitates were then analyzed by Western
blotting (WB) with anti-CaMKKa and anti-14-3-3g. Protein molec-
ular weight markers (in kDa) are shown to the left. (B) Control and
CaMKKa immunocomplexes were analyzed as in (A) using speciﬁc
antibodies to 14-3-3b, c, and e isoforms.
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genesis protocol. WT and mutant CaMKKa plasmids were expressed
in Escherichia coli BL21 cells with 30 mM isopropyl-1-thio-b-D-galac-
topyranoside at 16–18 C for 12 h and then puriﬁed by aﬃnity chroma-
tography on CaM-Sepharose resin [9]. GST-14-3-3 isoforms were
expressed in JM109 cells and puriﬁed as described [8]. CaM and the
catalytic subunit of PKA were isolated from bovine and porcine brain,
respectively [10,11]. Antibodies to CaMKKa (SC-11370) and 14-3-3
isoforms (b, 18641; c, 18647; e, 18643, g, 18645) were purchased from
Santa Cruz Biotechnology and Immuno-Biological Laboratories,
respectively.
2.2. Quantitative proteomics
PC12Mh cells (1 · 108 [8]) stably expressing MEF-fused 14-3-3 (g-
isoform) were metabolically labeled with [13C] Lys/Arg for 9 days. The
labeled cells were stimulated with 50 mM forskolin (Sigma) for 20 min,
lysed in 3 ml of lysis buﬀer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl,
10% (w/v) glycerol, 100 mM NaF, 10 mM EGTA, 1 mM Na3VO4, 1%
(w/v) Triton X-100, 5 mM ZnCl2, 2 mM phenylmethylsulfonyl ﬂuo-
ride, 10 lg/ml aprotinin, and 1 lg/ml leupeptin), and combined with
an equal volume of the lysate from non-labeled, unstimulated PC12Mh
cells. Proteins bound to the expressed MEF-14-3-3g protein were then
puriﬁed from the combined lysates by the MEF method [8]. The recov-
ered proteins were identiﬁed and quantiﬁed by two-dimensional liquid
chromatography-tandem mass spectrometry following digestion with
trypsin [8].
2.3. Phosphorylation and binding assay
Phosphorylation of WT and mutant CaMKKa proteins by PKA
was carried out at 30 C for 20 min in a 25 ll ﬁnal volume reaction
(50 mM HEPES, pH 7.5, 10 mM magnesium acetate, 0.1 mM ATP,
0.25 ll of PKA, and 0.1 lg of WT-CaMKKa or mutant proteins) in
the presence or absence of GST-14-3-3g (2 lg). For the quantiﬁcation
of phosphate content, the WT and mutant CaMKKa proteins (0.2 lg)
were phosphorylated under the above conditions in the presence of
5 mCi [c-32P] ATP. For the GST pull-down experiments, glutathi-
one–agarose beads (Pharmacia) were added to the reaction and incu-
bated for 60 min at 4 C, and the protein complex bound to the
beads were washed ﬁve times with buﬀer A (20 mM Tris–HCl, pH
7.5, 150 mM NaCl) and solubilized in SDS–PAGE sample buﬀer.
For co-immunoprecipitation, Hek293 cells were transiently transfected
with the expression plasmids encoding FLAG-14-3-3g [8] and the cat-
alytic subunit of PKA [11], together with WT or mutant CaMKKa
proteins (in pcDNA3, Invitrogen). After 48 h, the expressed FLAG-
14-3-3g was immunoprecipitated with anti-FLAG-Sepharose (Sigma),
washed ﬁve times with buﬀer A, and the bound CaMKKa proteins
were released from the beads with 1 mM synthetic phosphopeptide
(LSQRQRSTpSTPNVHA, based on residues 250–265 of cRaf1 [5]).
Proteins were separated by 10% SDS–PAGE and analyzed by Western
blotting using speciﬁc antibodies (see ﬁgure legends).
2.4. CaMKK assay
CaMKKa activity was assayed at 30 C for 5 min in a 25 ll solution
containing 50 mM HEPES, pH 7.5, 10 mM magnesium acetate, 1 mM
CaCl2, 0.1 mM ATP, 5 mCi [c-
32P] ATP, 1 lg CaM, 10 lg of GST-
CaMKI (residues 1–293) [12] and varying amounts of GST-14-3-3
proteins (see ﬁgure legends). The reaction was initiated adding phos-
phorylated or non-phosphorylated enzyme (5 ng) and terminated by
adding SDS. Proteins were analyzed by 10% SDS–PAGE followed
by autoradiography. Incorporation of 32P was measured by scintilla-
tion counting of excised GST-CaMKI bands.3. Results
We identiﬁed CaMKKa as a 14-3-3g-binding partner using
our mass spectroscopy-based quantitative proteomics tech-
niques combined with stable isotope labeling and tandem-
aﬃnity puriﬁcation. This interaction was markedly enhanced
(>10-fold) following forskolin stimulation in PC12Mh cells
(data not shown). This result was further conﬁrmed by co-
immunoprecipitation with CaMKKa and 14-3-3g endoge-nously expressed in naı¨ve PC12 cells (Fig. 1A). We also con-
ﬁrmed that several 14-3-3 isoforms other than g, such as b,
c, and e, formed similar complexes with CaMKKa under the
same conditions (Fig. 1B).
Davare et al. [7] reported that 14-3-3 bound CaMKKa
through site-speciﬁc phosphorylation on Ser74. To examine
whether Ser74 represents the only CaMKKa binding site for
14-3-3, we performed a pull-down experiment with GST-14-
3-3g-agarose beads and a S74A CaMKKa point mutant.
The S74A mutant bound to GST-14-3-3g similar to the WT
protein in the presence of PKA (see Fig. 2D, left panel, lane
4; compare with lane 2). We also analyzed this mutant in a
co-immunoprecipitation assay in Hek293 cells, but found no
signiﬁcant diﬀerences between the WT and S74A mutant
protein (see Fig. 2D, right panel, lane 4; compare with lane
2). Previous studies have shown that PKA phosphorylates
CaMKKa at multiple sites, including Ser52, Ser74, Thr108,
Ser458, and Ser475 ([9], Fig. 2A). We hypothesized therefore
that a PKA-phosphorylatable residue(s) other than Ser74
might also play a role in the present interaction. To test this
assumption and further specify the residue(s), we generated
CaMKKa quadruple mutants, in which four of the ﬁve phos-
phorylatable residues were simultaneously substituted with
alanine, termed S52f (S74/T108/S458/S475A), S74f (S52/
T108/S458/S475A), T108f (S52/S74/S458/S475A), S458f (S52/
S74/T108/S475A), and S475f (S52/S74/T108/S458A), and the
all-site mutant (all mut) (Fig. 2A), and these mutant proteins
were analyzed in a GST pull-down assay. We found that, like
WT and S74f, S475f bound directly to GST-14-3-3g only when
it was phosphorylated by PKA (Fig. 2B, lane 12). A much low-
er but detectable amount of S52f was also found to associate
with GST-14-3-3g under the PKA-phosphorylation conditions
(Fig. 2B, lane 4). In contrast, no binding was detected with the
T108f, S458f, and all mut proteins even though PKA phos-
phorylated these mutants (except for the all mut protein) to
a similar extent as the other constructs (Fig. 2C). These ﬁnd-
ings suggest that Ser74 and Ser475 may be the primary sites
for the observed 14-3-3 binding, although Ser52 might also
play a role. This conclusion was further conﬁrmed with a
S74A/S475A double mutant. A signiﬁcant reduction in 14-3-
3g binding was indeed observed only upon combination of
theses mutations by both GST pull-down and co-immunopre-
cipitation assays in Hek293 cells (Fig. 2D, lane 8).
Fig. 2. 14-3-3 Binds CaMKKa through PKA-mediated phosphorylation of Ser74 and Ser475. (A) Schematic illustration of WT and mutant
CaMKKa. For WT-CaMKKa, the catalytic domain, the regulatory domain, and the reported phosphorylation sites via PKA are indicated. For
mutants, the mutated alanine is indicated by A. (B) Binding of 14-3-3g to CaMKKa phosphorylated by PKA on Ser74 and Ser475. The indicated
CaMKKa proteins were incubated with GST-14-3-3g (lanes 1–14) or GST alone (lanes 15, 16) in the absence or presence of the PKA catalytic
subunit, pulled-down with glutathione–agarose beads, and the precipitates were separated by 10% SDS–PAGE and analyzed by Western blotting
(WB) with anti-CaMKKa to detect the co-precipitated CaMKKa (upper panel) and by Coomassie blue staining (CBB) to monitor the protein levels
of GST-14-3-3g and GST in the precipitate (lower panel). Protein molecular weight markers (in kDa) are shown to the left. (C) Analysis of the
amounts of phosphate incorporated into WT and mutant CaMKKa proteins. The indicated CaMKKa proteins were incubated with the PKA
catalytic subunit for 20 min in the presence of [c-32P] ATP and analyzed by 10% SDS–PAGE followed by CBB (left, upper panel) and
autoradiography (Autorad) (left, lower panel). The corresponding protein bands were also excised, and the amount of 32P was measured by
scintillation counting (right panel). (D) Ser74 and Ser475 are the primary sites within CaMKKa responsible for 14-3-3 binding. Pull-down
experiments were carried out under the conditions shown in (B) with the indicated CaMKKa proteins and GST-14-3-3g (left panel). Co-
immunoprecipitation assays were performed with the indicated CaMKKa proteins and FLAG-14-3-3g (right panel). Similar results were obtained
for at least three independent experiments.
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lated targets; these eﬀects include regulation of the subcellular
localization of the targets [1–4]. Because CaMKKa localizes
both to the nucleus and to the cytoplasm [6], we hypothesized
that 14-3-3 might regulate the intracellular localization of
CaMKKa through a phosphorylation-dependent interaction.
Immunoﬂuorescence staining of WT and the double mutant
(S74A/S475A) of CaMKKa expressed in Hek293 cells together
with the catalytic subunit of PKA revealed, however, no signif-
icant diﬀerences between the staining patterns of these two
proteins (mainly cell body, data not shown), suggesting that
the association with 14-3-3 is not essential for the observed
CaMKKa localization (at the current detectable level).
Another potential eﬀect of the 14-3-3 binding on CaMKKa
is that 14-3-3 might regulate the catalytic activity of CaMKKa.
To test this possibility, WT-CaMKKa was incubated with or
without the catalytic subunit of PKA at 30 C for 20 min
and then the enzymatic activity was measured in the presence
or absence of GST-14-3-3g using GST-CaMKI (residues 1–
293) as a substrate. As shown in Fig. 3A, the activity of
puriﬁed, PKA-phosphorylated CaMKKa was 20% less than
non-phosphorylated CaMKKa (both in the absence of GST-14-3-3g), which is consistent with a previous report showing
that PKA directly inhibits this kinase [13,14]. We found, how-
ever, that the addition of GST-fused 14-3-3g protein to the as-
say inhibited the activity of CaMKKa by 80% (Fig. 3A). This
inhibitory eﬀect was dose dependent (Fig. 3A), and kinetic
studies showed that the inhibition was due to a decrease in
the Vmax of CaMKKa (Fig. 3B). In contrast, GST-14-3-3g
did not aﬀect CaMKKa inhibition when PKA was omitted
from the reaction or when a V180D point mutant of GST-
14-3-3g was used – in which Val180 was mutated to Asp [8]
– a mutation known to disrupt the 14-3-3g interaction with
a variety of target proteins (Fig. 3A). These results demon-
strated that the inhibitory eﬀect was speciﬁc. The GST-14-3-
3g added to the reaction did not aﬀect the rate or ﬁnal level
of the phosphorylation of CaMKKa by PKA, as judged by
autoradiography using [c-32P] ATP (data not shown). These
ﬁndings suggest that the observed inhibitory eﬀect of 14-3-3
is mediated through direct binding of 14-3-3 with phosphory-
lated enzyme. Similar results were obtained with all other
GST-14-3-3 isoforms tested (Fig. 3C), consistent with the
observation that these fusions also bound speciﬁcally to CaM-
KKa in a PKA-dependent manner (data not shown).
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Fig. 3. 14-3-3 Inhibits the catalytic activity of CaMKKa. (A) Puriﬁed CaMKKa was incubated for 20 min in the absence (PKA) or presence of
PKA (+PKA) and analyzed for its kinase activity in the presence of GST-14-3-3g (closed circle) or V180D mutant GST-14-3-3g (open circle). The
results are expressed as a percentage of the activity in the absence of both PKA and GST-14-3-3g (means ± S.E.M. of at least six experiments). (B)
CaMKKa activities were measured with various concentrations of ATP (10–100 lM) or CaMKI (1–10 lg) in the absence (GST-14-3-3g) or
presence of GST-14-3-3g (GST-14-3-3g+) as in (A). The results represent the mean of two experiments and are presented as double reciprocal plots
(Lineweaver-Burk). (C) CaMKKa activities were measured as in (A) in the presence of the indicated GST-14-3-3 isoforms (1 lg each).
Fig. 4. Ser74 and Ser475 are both functional for 14-3-3g-mediated
inhibition of CaMKKa. Protein kinase activities were measured with
WT CaMKKa (open circle), or mutants S74A (closed square), S475A
(closed triangle), or S74A/S475A (closed circle) in the presence of the
indicated amounts of GST-14-3-3g after phosphorylation by PKA
(solid lines). Control experiments were performed as above without
PKA (dotted lines). Similar results were obtained with independently
prepared CaMKKa samples.
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eﬀect of the single and double alanine substitution (S74A,
S475A, and S74A/S475A) on the kinase assay. As shown in
Fig. 4, the S74A and S475A mutants, but not the S74A/
S475A double mutant, were similarly inhibited by GST-14-3-
3g in a dose-dependent manner (Fig. 4). Thus, Ser74 and
Ser475 are both functional for the observed 14-3-3-mediated
inhibition of CaMKKa activity. Our results, however, cannot
exclude the possibility that an additional residue(s) on CaM-
KKa, e.g., Ser52, might also participate in the present regula-
tion, because the S74A/S475A double mutant was still
inhibited by GST-14-3-3g at lower, but detectable levels
(Fig. 4).4. Discussion
The CaM kinase cascade, consisting of CaMKKa (and pos-
sibly CaMKKb) and the two major downstream targets, CaM-
KI and CaMKIV, is involved in diverse cellular responses, and
therefore proper regulation of this cascade system is critical for
maintaining normal cell growth and function [6]. There is
extensive cross-talk between this system and other signal trans-
duction pathways, including those that involve MAPKs, PKB,
and PKA. Wayman et al. [13] and Matsushita and Nairn [14]
showed that PKA negatively regulates CaMKKa through
phosphorylation of Thr108 and possibly Ser458. The 14-3-3
protein was proposed to stabilize the phosphorylated, enzy-
matically inactive form by binding to Ser74, another PKA-
phosphorylation site of CaMKKa [7]. In the present study,
we report that the binding of 14-3-3 to CaMKKa is mediated
by at least two speciﬁc phosphorylations by PKA on Ser74 and
Ser475 (Fig. 2). We also demonstrate that the interaction be-
tween 14-3-3 and Ser74 or Ser475 directly inhibits CaMKKa
activity (Figs. 3 and 4). These ﬁndings suggest additional func-
tional implications for 14-3-3 in PKA-dependent regulation of
CaMKKa. We propose that 14-3-3 is an important regulator
of cross-talk between the CaM kinase cascade and PKA sig-
naling mechanisms.
The amino acid sequences surrounding Ser74 and Ser475 are
highly conserved among various CaMKKa proteins from dif-
ferent species as well as among other CaMKK isozymes,
including CaMKKb [15]. Furthermore, the sequences sur-
rounding these residues have striking similarity to the 14-3-3
protein recognition sequences, such as the ones present in
Raf, AANAT and tyrosine hydroxylase [1–5]. These ﬁndings
suggest that 14-3-3 may also regulate these CaMKK proteins
in concert with phosphorylation via PKA. Consistent with this
ﬁnding, we found that GST-14-3-3g bound rat CaMKKb
phosphorylated by PKA in a GST pull-down experiment and
co-immunoprecipitation assay using Hek293 cells, although
the function of this interaction is unknown (data not shown).
It may be possible that a diﬀerent or unidentiﬁed kinase also
participates in controlling the CaMKK isozymes by inducing
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tein kinases is a widely recognized feature of signal integration.
In this regard, we note a recent report showing that a death
agonist-regulated kinase (DARK [16]) phosphorylates human
CaMKKb at Ser511, which is comparable to Ser475 in rat
CaMKKa, a site identiﬁed in this study as a new 14-3-3-bind-
ing site.
During the preparation of this manuscript, Davare et al. [7]
reported that 14-3-3 binds and regulates a recombinant (GST-
fused) CaMKKa phosphorylated by PKA. Unlike the present
results, however, they showed that this interaction was isoform
speciﬁc (14-3-3c and g isoforms) and occurs through site-spe-
ciﬁc phosphorylation of Ser74. Moreover, the reported eﬀect
by 14-3-3 (c isoform) seems indirect because it was not de-
tected until the recombinant CaMKKa was simultaneously
mutated at Thr108 and Ser458. Although the exact reason
for this disparity between our results and those of Davare
et al. [7] remains to be determined, our results strongly suggest
that 14-3-3 binds CaMKKa at multiple sites and inhibits
CaMKKa activity directly. This mode of regulation is the
one collectively called ‘‘mode C regulation’’ [3]. Further struc-
tural studies are needed, however, to clarify the molecular
mechanism of the present interaction. It is also necessary to
determine the physiological signiﬁcance of this regulation.
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